Avoro Capital Advisors LLC Diversified Active

Location: NEW YORK, NY

CIK: 0001633313 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $6,406,568 (100.0% shares, 0.0% debt)

Holdings (33)

UTHR UNITED THERAPEUTICS CORP 12.9%
Value ($000) $824,622 Shares 2,675,000 Est. Cost $134.94 Unrealized +154.0%
ASND ASCENDIS PHARMA 12.7%
Value ($000) $813,277 Shares 5,218,000 Est. Cost $127.83 Unrealized
ARGX ARGENX SE 11.4%
Value ($000) $731,058 Shares 1,235,177 Est. Cost $186.36 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 10.5%
Value ($000) $669,821 Shares 2,022,222 Est. Cost $138.83 Unrealized +136.7%
KRYS KRYSTAL BIOTECH INC 7.7%
Value ($000) $492,399 Shares 2,731,000 Est. Cost $89.11 Unrealized +88.8%
BLUEPRINT MEDICINES CORP 5.3%
Value ($000) $340,764 Shares 3,850,000 Est. Cost $88.11 Unrealized
APLS APELLIS PHARMACEUTICALS INC. 4.2%
Value ($000) $267,300 Shares 12,222,222 Est. Cost $47.01 Unrealized -41.2%
RNAM AVIDITY BIOSCIENCES INC 3.5%
Value ($000) $225,090 Shares 7,625,000 Est. Cost $22.48 Unrealized +38.5%
XENE XENON PHARMACEUTICALS INC 3.0%
Value ($000) $192,633 Shares 5,741,666 Est. Cost $19.12 Unrealized +98.6%
SLNO SOLENO THERAPEUTICS INC 2.8%
Value ($000) $180,411 Shares 2,525,000 Est. Cost $40.48 Unrealized +20.3%
KYMR KYMERA THERAPEUTICS INC 2.8%
Value ($000) $176,810 Shares 6,460,000 Est. Cost $35.31 Unrealized +3.2%
SRPT SAREPTA THERAPEUTICS INC 2.7%
Value ($000) $170,708 Shares 2,674,835 Est. Cost $106.36 Unrealized -1.0%
FOLD AMICUS THERAPEUTICS INC. 2.6%
Value ($000) $167,280 Shares 20,500,000 Est. Cost $10.47 Unrealized -11.6%
ARWR ARROWHEAD PHARMACEUTICALS INC. 2.2%
Value ($000) $141,556 Shares 11,111,111 Est. Cost $29.27 Unrealized -37.9%
VERA VERA THERAPEUTICS INC 2.1%
Value ($000) $136,960 Shares 5,701,900 Est. Cost $37.55 Unrealized -14.4%
MERUS N V 2.0%
Value ($000) $126,270 Shares 3,000,000 Est. Cost $39.83 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 1.7%
Value ($000) $108,228 Shares 2,770,100 Est. Cost $35.93 Unrealized +19.9%
INTRA-CELLULAR THERAPIES INC 1.3%
Value ($000) $82,450 Shares 625,000 Est. Cost $70.93 Unrealized
ALKS ALKERMES PLC 1.3%
Value ($000) $80,899 Shares 2,450,000 Est. Cost $28.75 Unrealized +13.4%
BCRX BIOCRYST PHARMACEUTICALS INC 1.0%
Value ($000) $65,250 Shares 8,700,000 Est. Cost $10.72 Unrealized -24.7%
OCUL OCULAR THERAPEUTIX INC 0.9%
Value ($000) $59,080 Shares 8,060,000 Est. Cost $6.99 Unrealized +9.9%
CNTA CENTESSA PHARMACEUTICALS PLC 0.9%
Value ($000) $58,239 Shares 4,050,000 Est. Cost $14.38 Unrealized
89BIO INC 0.7%
Value ($000) $46,165 Shares 6,350,000 Est. Cost $7.63 Unrealized
MNKD MANNKIND CORP 0.7%
Value ($000) $44,013 Shares 8,750,000 Est. Cost $3.56 Unrealized +57.5%
PCVX VAXCYTE INC 0.6%
Value ($000) $37,760 Shares 1,000,000 Est. Cost $79.91 Unrealized +0.1%
TOURMALINE BIO INC 0.6%
Value ($000) $36,884 Shares 2,425,000 Est. Cost $23.43 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL INC 0.5%
Value ($000) $30,054 Shares 830,000 Est. Cost $49.13 Unrealized -15.3%
TSHA TAYSHA GENE THERAPIES INC 0.4%
Value ($000) $27,800 Shares 19,999,999 Est. Cost $2.04 Unrealized -18.0%
QURE UNIQURE NV 0.4%
Value ($000) $23,055 Shares 2,175,000 Est. Cost $8.63 Unrealized +62.4%
GLUE MONTE ROSA THERAPEUTICS INC 0.3%
Value ($000) $21,555 Shares 4,645,548 Est. Cost $13.91 Unrealized -55.9%
AUTL AUTOLUS THERAPEUTICS PLC 0.2%
Value ($000) $15,361 Shares 9,910,642 Est. Cost $6.38 Unrealized
SEPN SEPTERNA INC 0.1%
Value ($000) $7,744 Shares 1,337,500 Est. Cost $21.57 Unrealized -47.1%
WHWK WHITEHAWK THERAPEUTICS INC 0.1%
Value ($000) $5,072 Shares 2,849,402 Est. Cost $24.27 Unrealized -89.2%